Inguinal hernia

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Retrieved on: 
Thursday, March 21, 2024
Vein, Consultant, Risk, Anatomy, Surgical mesh, Trauma, Chronic pain, Artery, Surgeon, AMS, FDA, Inguinal hernia, Suture

(NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the U.S. launch of LIQUIFIX FIX8™ Laparoscopic and LIQUIFIX Precision™ Open Hernia Mesh Fixation Devices.

Key Points: 
  • (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the U.S. launch of LIQUIFIX FIX8™ Laparoscopic and LIQUIFIX Precision™ Open Hernia Mesh Fixation Devices.
  • LIQUIFIX FIX8 is indicated for minimally invasive femoral and inguinal hernia repairs; and LIQUIFIX Precision is indicated for open femoral and inguinal hernia repairs.
  • The LIQUIFIX devices are the only FDA-approved devices that affix mesh and approximate peritoneal tissue with liquid anchors.
  • LIQUIFIX hernia mesh fixation devices eliminate the need for penetrating mechanical tacks, sutures, or staples by delivering a liquid adhesive that allows for precise and controlled mesh fixation.

Global Hernia Mesh Devices Market Size, Share & Trends Analysis Report 2023: Market to Reach $8.3 Billion by 2030 - Innovation in Enhancing Patient Outcomes Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, October 13, 2023
Medical Supplies, Medical Devices, Health, Surgery, General Health, Biotechnology, Incidence, Femoral hernia, Hernia, Capillary action through synthetic mesh, Prevalence, Inguinal hernia, USD, Biomesh, Growth, Incisional hernia, Operation Time, Patient, Thermoplastic, Pharmaceutical industry

The "Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global hernia mesh devices market size is expected to reach USD 8.3 billion by 2030.
  • Additionally, the market benefits from a favorable reimbursement scenario, which encourages patients to opt for hernia surgeries, further boosting market growth.
  • Among hernia types, inguinal hernia repair devices hold a substantial market share, thanks to the wide range of available mesh products designed specifically for inguinal repair.

Worldwide Cardiovascular and Soft Tissue Repair Patches Industry to 2030 - Featuring Baxter, LabCor and Neovasc Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 1, 2022
Medical Supplies, Medical Devices, Health, Surgery, Cardiology, Biotechnology, Umbilical hernia, Adoption, Ventricular septal defect, Degenerative disease, Death, Congenital diaphragmatic hernia, Ascites, Prevalence, Korea Disease Control and Prevention Agency, Coronary heart disease, susceptibility to, 8, Risk, Birth defect, Growth, Smoking, ASD, Chronic cough, Hernia, Obesity, Inguinal hernia, Atrial septal defect, Constipation, Center, Pressure, World Health Organization, Incidence, Polytetrafluoroethylene, Pharmaceutical industry, Health insurance

In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years.

Key Points: 
  • In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years.
  • One of the key driving market forces is the rapidly rising prevalence of cardiovascular diseases.
  • As per World Health Organization estimates, cardiovascular diseases account for the largest share of 32% or 17.9 million deaths annually.
  • As per the Centers for Disease Control and Prevention estimates, approximately 695,000 deaths in the U.S. are due to underlying cardiac diseases.

Global Inguinal Hernia Industry Outlook, 2026 - Market Dynamics, Regulatory & Patent Analysis, Company Share Analysis, Product Profiles, Porter's Five Forces Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, February 25, 2022
Biotechnology, Pharmaceutical, Health, Row, SME, Competitive landscape, Partnership, Acquisition, COVID-19, CAGR, Lists of people executed in the United States, Inguinal hernia, Retail, Marketing, Pet, Animal, Thermoplastic

This segment of the report provides a brief competitive analysis of Inguinal Hernia, to help understand the competition in the market.

Key Points: 
  • This segment of the report provides a brief competitive analysis of Inguinal Hernia, to help understand the competition in the market.
  • This segment illustrates the global market of Inguinal Hernia along with the market segmentation.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Inguinal Hernia market.
  • Which are the regions and countries where companies should have concentrated on opportunities for Inguinal Hernia market growth in the coming future?

Worldwide Hernia Repair Devices and Consumables Industry to 2028 - by Hernia Type, Surgery Type, Component and Region

Retrieved on: 
Thursday, March 4, 2021
Medicine, Hernias, Clinical medicine, Medical specialties, Digestive system surgery, Acute pain, Biomesh, Ethicon Inc., Johnson & Johnson, Inguinal hernia, Surgical mesh

However, the inadequate reimbursement policies and high cost of hernia repair surgeries are factors that are significantly limiting the expansion of the hernia repair devices and consumables market's progress globally.

Key Points: 
  • However, the inadequate reimbursement policies and high cost of hernia repair surgeries are factors that are significantly limiting the expansion of the hernia repair devices and consumables market's progress globally.
  • Globally, North America holds the largest market for hernia repair devices and consumables, and is likely to continue dominating the market till 2028.
  • Hence, these factors are likely to augment the growth of the hernia repair devices and consumables market in North America.
  • Ethicon Inc functions as a Johnson and Johnson subsidiary, primarily engaged in providing hernia repair and fixation products, including hernia mesh, hernia biologic mesh, hernia tissue separation mesh, and hernia flat mesh devices.

Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI) implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults

Retrieved on: 
Thursday, October 29, 2020
Medical specialties, Clinical medicine, Medicine, Digestive system surgery, Acetanilides, Bupivacaine, Piperidines, Hernias, Inguinal hernia, Hernia repair, Inguinal, Local anesthetic

XARACOLL will be launched through a partnership between Mallinckrodt Pharmaceutical's Acute Care Sales Team and Innocoll's Hospital Sales Team.

Key Points: 
  • XARACOLL will be launched through a partnership between Mallinckrodt Pharmaceutical's Acute Care Sales Team and Innocoll's Hospital Sales Team.
  • In two Phase III studies, XARACOLL met the primary endpoint demonstrating statistically significant pain relief through 24 hours in patients undergoing open inguinal hernia repair while also decreasing the amount of opioids needed following surgery.
  • Safety and efficacy of bupivacaine HCl collagen-matrix implant (INL-001) in open inguinal hernia repair: results from two randomized controlled trials.Adv Ther.
  • XARACOLL contains an amide local anesthetic and is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults

Retrieved on: 
Monday, August 31, 2020
Medical specialties, Clinical medicine, Medicine, Digestive system surgery, Hernias, Inguinal hernia, Scrotum, Inguinal, Local anesthetic, Surgery, Femoral hernia, Hydrocele

The efficacy and safety of XARACOLL was evaluated in two Phase III studies of identical design in open inguinal hernia repair.

Key Points: 
  • The efficacy and safety of XARACOLL was evaluated in two Phase III studies of identical design in open inguinal hernia repair.
  • XARACOLL provided statistically significant pain relief through 24 hours versus placebo, the primary endpoint for both studies.
  • "We look forward to sharing our Phase III data with surgeons as we introduce this new option to manage acute pain following open inguinal hernia repair in adults."
  • XARACOLL contains an amide local anesthetic and is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.

$4.4 Billion Hernia Repair Devices Market Assessment, 2020-2027 - Rising Adoption of Tension-Free Repair Procedures, Increasing Demand for Minimally Invasive Procedures

Retrieved on: 
Thursday, August 27, 2020
Medicine, Clinical medicine, Medical specialties, Digestive system surgery, Hernias, Hernia repair, Robot-assisted surgery, Laparoscopy, Surgery, Inguinal hernia surgery, Inguinal hernia

An increasing number of patients suffering from obesity and the rise in the ageing population who are vulnerable to develop a hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving the growth of hernia repair devices market.

Key Points: 
  • An increasing number of patients suffering from obesity and the rise in the ageing population who are vulnerable to develop a hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving the growth of hernia repair devices market.
  • However, inconsistent reimbursement and the high cost of the hernia repair procedure, high implementation cost and regulations posed on robotic surgery, operation failure and recurrence of hernia and also the risks and complications associated with hernia repair surgery and meshes are negatively influencing the expansion of hernia repair devices market.
  • The Hernia repair devices global market is segmented based on products, hernia types, repair types, end-users and geography.
  • Based on the types of repair procedures, the market is divided into open tension-free repair, laparoscopic repair and robotic-assisted hernia repair types.

TransEnterix Announces Submission of General Surgery Expansion in the US

Retrieved on: 
Tuesday, August 4, 2020
FDA, Health, Surgery, Medical devices, Clinical medicine, Medicine, Medical specialties, Digestive system surgery, Hernia repair, Inguinal hernia surgery, Robot-assisted surgery, Laparoscopy, Cholecystectomy, General surgery, Inguinal hernia, Surgery

This submission is an important milestone for the continued application of Senhance in the highest volume and value procedures, said Anthony Fernando, president and chief executive officer at TransEnterix.

Key Points: 
  • This submission is an important milestone for the continued application of Senhance in the highest volume and value procedures, said Anthony Fernando, president and chief executive officer at TransEnterix.
  • The Senhance System is also the first machine-vision system in robotic surgery which is powered by the new intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery.
  • The Senhance Surgical System is intended for use in laparoscopic gynecological surgery, colorectal surgery, cholecystectomy, and inguinal hernia repair.
  • This press release includes statements relating to the Senhance System and the Companys submission of an indication filing to the FDA to expand General Surgery usage of the Senhance Surgical System.

Hernia Repair Devices and Consumables Market to Reach $6.35 Bn, Globally, by 2027 at 3.6% CAGR: AMR

Retrieved on: 
Monday, July 13, 2020
Hernias, Medicine, Anatomy, Clinical medicine, Hernia repair, Inguinal hernia, Femoral hernia, Incisional hernia, Umbilical hernia, Inguinal, Inguinal hernia surgery, Biomesh

PORTLAND, Oregon, July 13, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, " Hernia Repair Devices and Consumables Market by Product (Fixation Devices and Consumables), Surgery Type (Open Tension-Free Repair Surgery and Laparoscopic surgery), and Hernia Type (Incisional Hernia, Umbilical, Inguinal Hernia, and Femoral Hernia): Global Opportunity Analysis and Industry Forecast, 20202027."

Key Points: 
  • PORTLAND, Oregon, July 13, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, " Hernia Repair Devices and Consumables Market by Product (Fixation Devices and Consumables), Surgery Type (Open Tension-Free Repair Surgery and Laparoscopic surgery), and Hernia Type (Incisional Hernia, Umbilical, Inguinal Hernia, and Femoral Hernia): Global Opportunity Analysis and Industry Forecast, 20202027."
  • According to the report, the global hernia repair devices and consumables industry generated $4.74 billion in 2019, and is projected to garner $6.35 billion by 2027, witnessing a CAGR of 3.6% from 2020 to 2027.
  • Rise in advanced meshes demand, surge in implementation of robotic surgeries, and increase in number of hernia patients drive the global hernia repair devices and consumables market.
  • The demand for hernia repair devices and consumables has significantly dropped during the coronavirus pandemic.